HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naren L Banik Selected Research

Antioxidants

11/2021Protective Effects of Estrogen via Nanoparticle Delivery to Attenuate Myelin Loss and Neuronal Death after Spinal Cord Injury.
8/2011Neuroprotective effects of genistein in VSC4.1 motoneurons exposed to activated microglial cytokines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naren L Banik Research Topics

Disease

41Glioblastoma (Glioblastoma Multiforme)
06/2016 - 07/2002
34Neoplasms (Cancer)
01/2016 - 07/2002
30Spinal Cord Injuries (Spinal Cord Injury)
02/2022 - 05/2003
23Neuroblastoma
07/2014 - 12/2006
20Inflammation (Inflammations)
01/2022 - 05/2008
10Gliosis
11/2021 - 06/2010
10Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2018 - 04/2003
9Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 05/2004
8Parkinson Disease (Parkinson's Disease)
01/2022 - 06/2008
8Multiple Sclerosis
01/2018 - 04/2003
8Wounds and Injuries (Trauma)
03/2010 - 05/2003
5Demyelinating Diseases (Demyelinating Disease)
10/2017 - 06/2008
5Brain Neoplasms (Brain Tumor)
08/2013 - 07/2002
4Optic Neuritis (Retrobulbar Neuritis)
10/2016 - 08/2005
4Parkinsonian Disorders (Parkinsonism)
10/2008 - 08/2006
3Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 06/2002
3Disease Progression
01/2020 - 10/2015
3Neuroinflammatory Diseases
02/2018 - 04/2003
3Meningioma (Meningiomas)
09/2015 - 07/2002
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2013 - 08/2005
3Edema (Dropsy)
05/2008 - 12/2004
2Vision Disorders (Hemeralopia)
10/2016 - 07/2011
2Necrosis
06/2016 - 12/2007
2Muscular Atrophy (Muscle Atrophy)
02/2016 - 11/2012
2Traumatic Brain Injuries (Traumatic Brain Injury)
01/2016 - 01/2016
2Nervous System Diseases (Neurological Disorders)
01/2016 - 06/2008
2Alzheimer Disease (Alzheimer's Disease)
01/2016 - 06/2008

Drug/Important Bio-Agent (IBA)

40CalpainIBA
01/2022 - 06/2002
17Estrogens (Estrogen)FDA Link
11/2021 - 11/2004
12Peptide Hydrolases (Proteases)FDA Link
01/2018 - 06/2003
11calpain inhibitorsIBA
01/2022 - 05/2003
10CaspasesIBA
06/2016 - 05/2003
10Caspase 3 (Caspase-3)IBA
03/2016 - 07/2002
10GenisteinIBA
01/2013 - 12/2006
10Paclitaxel (Taxol)FDA LinkGeneric
12/2012 - 11/2007
10FenretinideIBA
05/2012 - 03/2008
9CytokinesIBA
10/2020 - 08/2011
9Small Interfering RNA (siRNA)IBA
10/2013 - 01/2009
9Telomerase (Telomerase Reverse Transcriptase)IBA
09/2013 - 12/2007
9retinamideIBA
05/2012 - 08/2008
9Interferon-gamma (Interferon, gamma)IBA
07/2010 - 05/2007
8Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2002
8ApigeninIBA
10/2013 - 12/2006
8Tretinoin (Retinoic Acid)FDA LinkGeneric
06/2010 - 05/2007
7Phosphopyruvate Hydratase (Enolase)IBA
09/2021 - 01/2016
71- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2020 - 06/2002
7calpeptinIBA
12/2018 - 08/2005
7Neuroprotective AgentsIBA
01/2016 - 11/2004
7Cysteine Proteases (Cysteine Protease)IBA
04/2011 - 05/2003
6RetinoidsIBA
11/2011 - 03/2008
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2013 - 12/2007
5SurvivinIBA
08/2013 - 12/2007
5MelatoninIBA
01/2013 - 05/2008
4Reactive Oxygen Species (Oxygen Radicals)IBA
11/2021 - 09/2007
4ChemokinesIBA
10/2020 - 01/2016
4Myelin Basic ProteinIBA
01/2018 - 10/2003
4AntigensIBA
10/2016 - 01/2011
4Phosphotransferases (Kinase)IBA
06/2016 - 09/2007
4Caspase 8 (Caspase-8)IBA
06/2016 - 12/2006
4Temozolomide (Temodar)FDA LinkGeneric
01/2015 - 12/2004
4RotenoneIBA
07/2014 - 08/2006
4FlavonoidsIBA
08/2012 - 12/2006
4Pharmaceutical PreparationsIBA
06/2012 - 04/2003
3SynucleinsIBA
01/2022 - 01/2019
3Sepharose (Agarose)IBA
01/2021 - 07/2002
3EnzymesIBA
10/2020 - 11/2012
3Peptides (Polypeptides)IBA
01/2018 - 05/2007
3Biological ProductsIBA
10/2017 - 08/2008
3Transcription Factors (Transcription Factor)IBA
06/2013 - 04/2011
3TeaIBA
02/2013 - 08/2011
3MicroRNAs (MicroRNA)IBA
02/2013 - 05/2012
3gallocatechol (epigallocatechin)IBA
02/2013 - 12/2006
3CurcuminIBA
12/2012 - 10/2006
3SteroidsIBA
06/2010 - 12/2004
3p38 Mitogen-Activated Protein KinasesIBA
01/2010 - 09/2007
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
11/2008 - 12/2007
3Dexamethasone (Maxidex)FDA LinkGeneric
05/2008 - 12/2004
3Caspase 9IBA
03/2008 - 07/2002
2AntioxidantsIBA
11/2021 - 08/2011
2Anti-Inflammatory Agents (Anti-Inflammatories)IBA
11/2021 - 11/2007
2ENOblockIBA
10/2020 - 10/2017
2Neurofilament ProteinsIBA
10/2016 - 01/2013
2Cathepsin BIBA
06/2016 - 06/2008
2salicylhydroxamic acid (SHAM)IBA
03/2016 - 02/2016
2UbiquitinIBA
02/2016 - 11/2012
2Ligases (Synthetase)IBA
02/2016 - 11/2012
2Biomarkers (Surrogate Marker)IBA
01/2016 - 01/2011
2Therapeutic UsesIBA
02/2015 - 10/2006
2RNA (Ribonucleic Acid)IBA
01/2014 - 07/2002
2calpastatinIBA
12/2013 - 11/2012
2diallyl trisulfideIBA
08/2013 - 09/2007

Therapy/Procedure

27Therapeutics
01/2022 - 04/2005
7Drug Therapy (Chemotherapy)
01/2015 - 07/2002
7Aftercare (After-Treatment)
11/2010 - 12/2007
4Radiotherapy
06/2016 - 07/2002
3Immunotherapy
04/2014 - 12/2007
2Laminectomy
03/2016 - 02/2016
2Lasers (Laser)
01/2016 - 08/2012
2Immunomodulation
07/2014 - 08/2013
2Intraperitoneal Injections
08/2013 - 07/2011